MedTrace Logo

A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

NCT06647264 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-10-17

No results posted yet for this study

Summary

Artificial intelligence technology is used to realize high-quality 3D scene reconstruction, whole process segmentation, scene activity understanding for common surgery guidance in hepatobiliary surgery, as well as intelligent identification, perception, early warning of key events in the whole process of endoscopic surgery (such as bleeding, blocking, tumor location, anastomosis, etc.), and decision-making assistance

Conditions

  • Hepatocellular Carcinomas
  • Cholecystectomy, Laparoscopic
  • Hepatectomy
  • Pancreatoduodenectomy

Sponsors & Collaborators

  • The Affiliated Hospital Of Southwest Medical University

    collaborator OTHER

  • Affiliated Hospital of Guangdong Medical University

    collaborator OTHER

  • Huzhou Central Hospital

    collaborator OTHER

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Jiangmen Central Hospital

    collaborator OTHER

  • Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

    collaborator OTHER

  • Chinese University of Hong Kong

    collaborator OTHER

  • Shenzhen Second People's Hospital

    collaborator UNKNOWN

  • Shenzhen Third People's Hospital

    collaborator UNKNOWN

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Kai Wang · Department of hepatobiliary surgery, Nanfang Hospital, Southern Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-09-01
Completion
2027-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06647264 on ClinicalTrials.gov